Location: Chongqing
Synced from ClinicalTrials.gov · August 07, 2026
Clinical studies recruiting near Chongqing
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav Phase 3 · Chongqing University Cancer Hospital · Pfizer · NCT05020236 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract Phase 3 · The First Affiliated Hospital of Chongqing Medical Universit · Eli Lilly and Company · NCT07218380 Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor Phase 1/Phase 2 · The First Affiliated Hospital of Chongqing Medical Universit · Sichuan Enray Pharmaceutical Sciences Company · NCT07433283 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W Phase 3 · The First Affiliated Hospital of Chongqing Medical Universit · Pfizer · NCT07028853 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line Phase 3 · Chongqing University Cancer Hospital ( Site 2041) · Merck Sharp & Dohme LLC · NCT06136559 A Phase 2 Study of HB0017 in Psoriasis Patients Phase 2 · Chongqing Traditional Chinese Medicine Hospital · Huabo Biopharm Co., Ltd. · NCT06592274 Indomethacin vs Diclofenac for Preventing PEP NA · The Second Affiliated Hospital of Chongqing Medical Universi · Air Force Military Medical University, China · NCT07071441 Efficacy and Safety of Liposomal Bupivacaine Injection for Paravertebral Nerve Block in the Treatment of Acute and Chron Phase 4 · The Second Affiliated Hospital of Chongqing Medical Universi · The Second Affiliated Hospital of Chongqing Medical Universi · NCT06569953 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod Phase 3 · The Southwest Hospital of AMU · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169 A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor Phase 1 · Chongqing University Cancer Hospital · Sichuan Baili Pharmaceutical Co., Ltd. · NCT05194982 Application of FAPI and FDG PET Imaging in Patients With Different Types of Cancer Phase N/A · Department of Nuclear Medicine, Daping Hospital of Army Medi · Daping Hospital and the Research Institute of Surgery of the · NCT06284070 Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC Phase 2 · Chongqing University Three Gorges Hospital · Guangdong Association of Clinical Trials · NCT05536505 Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome Phase 4 · Shapingba District People's Hospital of Chongqing · Shandong First Medical University · NCT06171061 Rectal NSAIDs With/Without PD Stent for PEP Prevention NA · Department of gastroenterology, Second Affiliated Hospital o · Air Force Military Medical University, China · NCT07117318 A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer Phase 1/Phase 2 · First Affiliated Hospital of Chongqing Medical University · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit Phase 1/Phase 2 · Local Institution - 0125 · Bristol-Myers Squibb · NCT07291076 The Chinese Familial Alzheimer's Network Phase N/A · Capital Medical University · NCT03657732 Virtual Ileostomy Versus Diverting Ileostomy in Patients Undergoing Total Mesorectal Excision NA · Daping Hospital, Third Military Medical University · Daping Hospital and the Research Institute of Surgery of the · NCT06633133 Prevention and Intervention of Overweight and Obesity in Preschool Children NA · Growth,Development and Mental Health of Children and Adolesc · Chen Li · NCT06562465 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov Phase 3 · The Second Affiliated Hospital of Chongqing Medical Universi · Amgen · NCT07037433 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis Phase 2 · Chongqing General Hospital · Eli Lilly and Company · NCT07415044 Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma Phase 2 · Xinqiao Hospital of Chongqing · Xinqiao Hospital of Chongqing · NCT05147844 Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients ( Phase 3 · Chongqing Cancer Hospital · Fudan University · NCT05909332 Prediction of Extubation Failure: A Multicenter Prospective Observational Study Phase N/A · The First Affiliated Hospital of Chongqing Medical Universit · Chongqing Medical University · NCT05069441 Hematopoietic Stem Cell-containing Autologous Blood Reinfusion for Bone Marrow Protection in Cervical Cancer Patients NA · Chongqing University Cancer Hospital · Chongqing University Cancer Hospital · NCT05401175 Child-Parent Familial Hypercholesterolemia Screening Phase N/A · Chongqin Medical University Affiliated Children's Hospital · Children's Hospital of Fudan University · NCT04529967 Functional Lung Avoidance Radiotherapy Guided by 4DCT Pulmonary Ventilation Function Imaging: A Prospective Single-arm C NA · Cancer Center, Second Affiliated Hospital of Chongqing Medic · The Second Affiliated Hospital of Chongqing Medical Universi · NCT07339644 Stepwise Strategy for Treatment of Atrialfibrillation Substrate Study Phase N/A · the second affiliated hospital of CQMU · Yuehui Yin · NCT07129564 Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis NA · Research Site · AstraZeneca · NCT07516184 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS Phase 3 · The Second Affiliated Hospital Chongqing Medical University · Eli Lilly and Company · NCT06890598
Look up another city
Look up another condition